A. Loonen

发表

A novel cryptic CBFB-MYH11 gene fusion present at birth leading to acute myeloid leukemia and allowing molecular monitoring for minimal residual disease

M. Veening, A. Ford, V. Haas, 2018 .

In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T‐cell acute lymphoblastic leukaemia

R. Pieters, M. Rots, W. Kamps, 2001, British journal of haematology.

In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions

R. Pieters, A. Veerman, K. Hählen, 1990 .

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

R. Pieters, A. Veerman, J. Harbott, 2000, Blood.

Genomic amplification of MYC as double minutes in a patient with APL-like leukemia

G. Ossenkoppele, H. Wessels, S. Zweegman, 2014, Molecular Cytogenetics.

sensitive subsets tipifarnib: identification of T-cell ALL and FAB M5 AML as the most In vitro profiling of the sensitivity of pediatric leukemia cells to

M. Heinrich, A. Harlow, D. Reinhardt, 2013 .

In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets.

M. Heinrich, A. Harlow, D. Reinhardt, 2005, Blood.

Vitamin A Does Not Enhance the Antileukemic Effect of Vincristine, Daunorubicin, and 6-Thioguanine in Acute Lymphoblastic Leukemia Cells

R. Pieters, A. Veerman, K. Hählen, 1994 .

Cytotoxic Effects of Vitamin A in Combination with Vincristine, Daunorubicin and 6‐Thioguanine upon Cells from Lymphoblastic Leukemic Patients

R. Pieters, A. Veerman, K. Hählen, 1991, Japanese journal of cancer research : Gann.

Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay.

R. Pieters, A. Veerman, G. Kaspers, 1994, British Journal of Cancer.

Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.

R. Pieters, A. Veerman, T. Hongo, 1992, British Journal of Cancer.

mediated multiple drugresistance in children withrelapsed acutelymphoblastic leukaemia

R. Pieters, A. Veerman, T. Hongo, 1992 .

Drug Resistance in Children with Relapsed Acute Lymphoblastic Leukemia

R. Pieters, A. Veerman, T. Hongo, 1992 .

In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.

R. Pieters, A. Veerman, K. Hählen, 1990, Blood.

In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.

R. Pieters, M. D. Den Boer, A. Veerman, 2002, Medical and pediatric oncology.

Cytostatic Drug Resistance in Childhood Relapsed Acute Lymphoblastic Leukemia

R. Pieters, A. Veerman, G. Henze, 1994 .

Large interindividual differences in cellular sensitivity to calicheamicin may influence gemtuzumab ozogamicin response in acute myeloid leukemia

D. Reinhardt, C. Zwaan, G. Kaspers, 2008, Leukemia.

Large Interindividual Differences in In Vitro Calicheamicin Sensitivity May Underly Gemtuzumab Ozogamicin Resistance in Acute Myeloid Leukemia (AML).

D. Reinhardt, C. Zwaan, J. Cloos, 2005 .

Features of proliferation and in vitro drug resistance in central primitive neuro‐ectodermal tumours

A. Veerman, P. Van Der Valk, H. C. van der Linden, 2002, Neuropathology and applied neurobiology.

DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effects.

G. Peters, H. Pinedo, G. Schwartsmann, 1988, Biochemical pharmacology.

Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.

R. Pieters, A. Veerman, G. Peters, 1992, Leukemia research.

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia

R. Pieters, A. Veerman, K. Hählen, 1991, The Lancet.

FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657.

D. Reinhardt, C. Zwaan, J. Cloos, 2010, Leukemia research.

Genomic amplification of MYC as double minutes in a patient with APL-like leukemia

G. Ossenkoppele, H. Wessels, S. Zweegman, 2014, Molecular Cytogenetics.

In Vitro Drug Resistance in Childhood Acute Lymphoblastic Leukemia in Relation to Age and Immunophenotype

R. Pieters, A. Veerman, G. Kaspers, 1992 .

Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.

R. Pieters, A. Veerman, E. V. van Wering, 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.

R. Pieters, A. Veerman, E. V. van Wering, 1993, Leukemia.

A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.

L. Boxer, B. Fine, G. Kaspers, 2005, Cancer research.

IN VITRO RESISTANCE TO CYTOSINE ARABINOSIDE, NOT TO DAUNORUBICIN, IS ASSOCIATED WITH THE RISK OF RELAPSE IN DE NOVO ACUTE MYELOID LEUKAEMIA

R. Pieters, A. Veerman, G. Ossenkoppele, 1996, British journal of haematology.

In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.

R. Pieters, A. Veerman, G. Henze, 1995, Blood.

In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.

R. Pieters, E. Klumper, E. V. van Wering, 1995, Leukemia.

Immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemia

R. Pieters, A. Veerman, A. Loonen, 1988, European journal of haematology.

A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin

G. Ossenkoppele, A. A. van de Loosdrecht, T. Westers, 2013, Cytometry. Part B, Clinical cytometry.

Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay

A. Moll, A. Veerman, P. Van Der Valk, 2001, Cancer.

Challenging diagnosis in a patient with clear lymphoid immunohistochemical features and myeloid morphology: mixed phenotype acute leukemia with erythrophagocytosis.

G. Ossenkoppele, A. A. van de Loosdrecht, T. Westers, 2011, Leukemia research.

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype

M. D. Boer, R. Pieters, A. Veerman, 2004, Leukemia.

In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia.

R. Pieters, A. Veerman, E. Klumper, 1995, British Journal of Cancer.

Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia

A. Veerman, G. Henze, K. Schmiegelow, 2003, British Journal of Cancer.

Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.

R. Pieters, A. Veerman, G. Henze, 2005, European journal of cancer.